文献速递神经MR

弥漫性中线胶质瘤H3 K27M突变状态的扩散与灌注成像生物标志物

Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.
PubMed 文献 · Neuroradiology · 2022-01-27

回顾性分析94例弥漫性中线胶质瘤(48例H3K27M突变型、46例野生型)的DWI和PWI特征,发现突变型瘤周ADC及nPT ADC更低,rCBV及nrCBV更高,PT ADC、nPT ADC和nrCBV可作为术前预测H3K27M突变状态的独立指标。

要点

  • 突变型瘤周ADC及nPT ADC均低于野生型,rCBV及nrCBV高于野生型。
  • PT ADC阈值1.245、nPT ADC阈值1.853、nrCBV阈值1.83为独立预测指标。
  • 丘脑弥漫性中线胶质瘤中突变型ADC相关值更低而nrCBV更高。

核心结论

  • DWI和PWI特征对弥漫性中线胶质瘤H3K27M突变状态的术前预测具有价值。

研究设计与样本

  • 回顾性研究,纳入2016年7月至2020年7月机构数据库94例弥漫性中线胶质瘤患者,其中突变型48例(51%)、野生型46例(49%);计算肿瘤ADC、瘤周ADC及其标准化值,灌注数据采用手动动脉输入函数和Boxerman-Weiskoff渗漏校正模型分析。

关键影像表现/征象

  • 突变型瘤周ADC为1.1 ± 0.33,野生型为1.23 ± 0.34(P = 0.033),突变型更低。
  • 突变型nPT ADC为1.64 ± 0.48,野生型为1.83 ± 0.54(P = 0.040),突变型更低。
  • 突变型rCBV为25.17 ± 27.76,野生型为13.73 ± 14.83(P = 0.018),突变型更高。
  • 突变型nrCBV为3.44 ± 2.16,野生型为2.39 ± 1.25(P = 0.049),突变型更高。
  • 丘脑弥漫性中线胶质瘤中,突变型min ADC、PT ADC、nADC及nPT ADC更低,nrCBV(校正与未校正)显著更高。

诊断标准与关键数值

  • PT ADC截断值1.245为H3K27M突变状态的显著独立预测指标。
  • nPT ADC截断值1.853为H3K27M突变状态的显著独立预测指标。
  • nrCBV截断值1.83为H3K27M突变状态的显著独立预测指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: H3K27M-mutant diffuse midline gliomas (M-DMGs) exhibit a clinically aggressive course. We studied diffusion-weighted imaging (DWI) and perfusion (PWI) MRI features of DMG with the hypothesis that DWI-PWI metrics can serve as biomarkers for the prediction of the H3K27M mutation status in DMGs.

METHODS: A retrospective review of the institutional database (imaging and histopathology) of patients with DMG (July 2016 to July 2020) was performed. Tumoral apparent diffusion coefficient (ADC) and peritumoral ADC (PT ADC) values and their normalized values (nADC and nPT ADC) were computed. Perfusion data were analyzed with manual arterial input function (AIF) and leakage correction (LC) Boxerman-Weiskoff models. Normalized maximum relative CBV (rCBV) was evaluated. Intergroup analysis of the imaging variables was done between M-DMGs and wild-type (WT-DMGs) groups.

RESULTS: Ninety-four cases (M-DMGs-n = 48 (51%) and WT-DMGs-n = 46(49%)) were included. Significantly lower PT ADC (mutant-1.1 ± 0.33, WT-1.23 ± 0.34; P = 0.033) and nPT ADC (mutant-1.64 ± 0.48, WT-1.83 ± 0.54; P = 0.040) were noted in the M-DMGs. The rCBV (mutant-25.17 ± 27.76, WT-13.73 ± 14.83; P = 0.018) and nrCBV (mutant-3.44 ± 2.16, WT-2.39 ± 1.25; P = 0.049) were significantly higher in the M-DMGs group. Among thalamic DMGs, the min ADC, PT ADC, and nADC and nPT ADC were lower in M-DMGs while nrCBV (corrected and uncorrected) was significantly higher. Receiver operator characteristic curve analysis demonstrated that PT ADC (cut-off-1.245), nPT ADC (cut-off-1.853), and nrCBV (cut-off-1.83) were significant independent predictors of H3K27M mutational status in DMGs.

CONCLUSION: DWI and PWI features hold value in preoperative prediction of H3K27M-mutation status in DMGs.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Kathrani, Chauhan, Kotwal, et al. Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas. Neuroradiology. 2022. PMID: 35083503. doi:10.1007/s00234-021-02857-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。